Posts

Mavacamten: a dawn to hypertrophic cardiomyopathy

on
0

Blood pressure medication should be viewed as an effective tool for reducing cardiovascular risk

on
0

The results of the LoDoCo2 trial establish colchicine as a potential new option for long-term prevention of CV events in patients with chronic coronary disease

on
0